During the past decade, Iatros International conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 10 clinical trials were completed, i.e. on average, 62.5% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 3 clinical trials were completed. i.e. 25% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Iatros International" #1 sponsor was "Pfizer" with 5 trials, followed by "Boehringer Ingelheim" with 3 trials sponsored, "Celldex Therapeutics" with 2 trials sponsored, "Biota Scientific Management Pty Ltd" with 1 trials sponsored and "Eli Lilly and Company" with 1 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 17 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Iatros International" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator, "Department of Health and Human Services" with 1 trials as a collaborator, "Incyte Corporation" with 1 trials as a collaborator, "Integrium" with 1 trials as a collaborator and "PPD" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 7 trials.

According to Clinical.Site data, the most researched conditions in "Iatros International" are "Cardiovascular Disease" (2 trials), "Adult Soft Tissue Sarcoma" (1 trials), "Alzheimer's Disease" (1 trials), "COVID" (1 trials) and "Chronic Inducible Urticaria" (1 trials). Many other conditions were trialed in "Iatros International" in a lesser frequency.

Most popular intervention types in "Iatros International" are "Drug" (22 trials), "Biological" (4 trials), "Other" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Empagliflozin" (2 trials), "Matching Placebo" (2 trials), "barzolvolimab" (2 trials) and "bococizumab (PF-04950615)" (2 trials). Other intervention names were less common.

The vast majority of trials in "Iatros International" are 24 trials for "All" genders.

Currently, there are NaN active trials in "Iatros International". undefined are not yet recruiting, 6 are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in Iatros International, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Iatros International, 0 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".